Exploring the Viability of Metabonomic Urinalysis as a Toxicity Screen Within a Pharmaceutical Drug Discovery Division

E-ISSN： 2212-1064|1|1|211-229

ISSN： 1574-0889

Source： Frontiers in Drug Design & Discovery, Vol.1, Iss.1, 2005-01, pp. : 211-229

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Multivariate Pharmaceutical Profiling for Drug Discovery

Current Topics in Medicinal Chemistry, Vol. 2, Iss. 1, 2002-01 ,pp. : 87-98

Bentham Science Publishers

Access to resources Recommend Favorite

Metabolic Stability Screen for Drug Discovery Using Cassette Analysis and Column Switching

Drug Metabolism Letters, Vol. 1, Iss. 1, 2007-01 ,pp. : 67-72

Bentham Science Publishers

Access to resources Recommend Favorite

System-based drug discovery within the human kinome

By Bamborough Paul

Expert Opinion on Drug Discovery, Vol. 7, Iss. 11, 2012-11 ,pp. : 1053-1070

Informa Healthcare

Access to resources Recommend Favorite

Metabonomic Applications in Toxicity Screening and Disease Diagnosis

Current Topics in Medicinal Chemistry, Vol. 2, Iss. 1, 2002-01 ,pp. : 35-51

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Thematic Issue: Systems and Network Biology in Pharmaceutical Drug Discovery)

Current Pharmaceutical Design, Vol. 20, Iss. 1, 2014-01 ,pp. : 2-3

Bentham Science Publishers

Access to resources Recommend Favorite